Clinipace Worldwide a global, digital clinical research organization (dCRO), today announced the addition of industry veteran Fred B. Davenport, Jr., to its Board of Directors.
As an independent director, Fred brings to Clinipace a significant pedigree in scaling global organizations within the CRO industry, having spent 10 years at Pharmaceutical Product Development, Inc. (PPD) during its rapid growth phase, followed by 6 years on the Board of Directors for Medpace, Inc. At PPD, Fred served in various roles, including General Counsel, Executive Vice President, and President.